Effect of Perception-based Interventions on Public Acceptance of Using Large Language Models in Medicine
NCT ID: NCT07304908
Last Updated: 2025-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
3000 participants
INTERVENTIONAL
2025-11-25
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Perceived benefits of large language models in medicine
Participants were asked to read "In April 2023, Massachusetts General Hospital launched a pilot program utilizing medical LLMs to assist with emergency department triage and initial diagnosis and observed a reduction in patient wait times and an improvement in clinical efficiency."
Perception-based interventions
Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.
Perceived racial bias in large language models in medicine
Participants were asked to read "In November 2022, a research team from the University of California, San Francisco found that cutting-edge medical LLMs exhibited racial bias when recommending treatment plans."
Perception-based interventions
Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.
Perceived ethical conflicts in large language models in medicine
Participants were required to read "In February 2023, a major European hospital network inadvertently leaked partially anonymized but still sensitive patient data during the testing of medical LLMs due to a system configuration error. Although no direct patient harm occurred, this increased public concerns regarding data privacy and security and compelled relevant institutions to conduct urgent reviews of their data protection measures."
Perception-based interventions
Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.
Control
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Perception-based interventions
Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of completing an online survey
* Agree to sign an informed consent form
Exclusion Criteria
* Not willing to participate in this study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Peking University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liu Jue
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jue Liu
Role: PRINCIPAL_INVESTIGATOR
Peking University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jue Liu
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NNSF72474005
Identifier Type: -
Identifier Source: org_study_id